VERADERMICS

Founded by dermatologists, Veradermics leverages its front-line clinical experience to identify and advance novel drugs that address specific patient needs and solve pervasive treatment challenges in dermatology practice. The company has cultivated a pipeline of diverse, first-in-class, therapeutics for highly prevalent dermatologic conditions seen in adults and children. Target indications include androgenetic alopecia (pattern hair loss), common warts (verruca vulgaris), alopecia areata, molluscum contagiosum, and atopic dermatitis. Veradermics' lead product candidate, VDPHL, offers a new, once-daily, non-hormonal oral treatment for pattern hair loss.. Veradermics is led by an executive team of board-certified dermatologists supported by a board of directors comprised of recognized biopharmaceutical industry leaders... Veradermics is committed to driving pharmaceutical innovation in dermatology with a curated pipeline of paradigm-shifting solutions to treat common skin conditions.....

Also known as: Veradermics, Inc.

Primary location: New Haven United States